Anti-FUT3 monoclonal antibody

Pre-made anti-FUT3 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to FUT3/FUT3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0076-Ab-1/ GM-Tg-hg-IP0076-Ab-2Anti-Human FUT3 monoclonal antibodyHuman
GM-Tg-rg-IP0076-Ab-1/ GM-Tg-rg-IP0076-Ab-2Anti-Rat FUT3 monoclonal antibodyRat
GM-Tg-mg-IP0076-Ab-1/ GM-Tg-mg-IP0076-Ab-2Anti-Mouse FUT3 monoclonal antibodyMouse
GM-Tg-cynog-IP0076-Ab-1/ GM-Tg-cynog-IP0076-Ab-2Anti-Cynomolgus/ Rhesus macaque FUT3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0076-Ab-1/ GM-Tg-felg-IP0076-Ab-2Anti-Feline FUT3 monoclonal antibodyFeline
GM-Tg-cang-IP0076-Ab-1/ GM-Tg-cang-IP0076-Ab-2Anti-Canine FUT3 monoclonal antibodyCanine
GM-Tg-bovg-IP0076-Ab-1/ GM-Tg-bovg-IP0076-Ab-2Anti-Bovine FUT3 monoclonal antibodyBovine
GM-Tg-equg-IP0076-Ab-1/ GM-Tg-equg-IP0076-Ab-2Anti-Equine FUT3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0076-Ab-1/ GM-Tg-hg-IP0076-Ab-2; GM-Tg-rg-IP0076-Ab-1/ GM-Tg-rg-IP0076-Ab-2;
GM-Tg-mg-IP0076-Ab-1/ GM-Tg-mg-IP0076-Ab-2; GM-Tg-cynog-IP0076-Ab-1/ GM-Tg-cynog-IP0076-Ab-2;
GM-Tg-felg-IP0076-Ab-1/ GM-Tg-felg-IP0076-Ab-2; GM-Tg-cang-IP0076-Ab-1/ GM-Tg-cang-IP0076-Ab-2;
GM-Tg-bovg-IP0076-Ab-1/ GM-Tg-bovg-IP0076-Ab-2; GM-Tg-equg-IP0076-Ab-1/ GM-Tg-equg-IP0076-Ab-2
Products NameAnti-FUT3 monoclonal antibody
Formatmab
Target NameFUT3
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-FUT3 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0076-Ag-1Recombinant multi-species FUT3/ CD174/ FT3B protein
    ORF Viral VectorvGMLP003593human FUT3 Lentivirus particle
    ORF Viral VectorpGMLP003593human FUT3 Lentivirus plasmid
    ORF Viral VectorvGMLV000456human FUT3 Lentivirus particle
    ORF Viral VectorpGMLV000456human FUT3 Lentivirus plasmid


    Target information

    Target IDGM-IP0076
    Target NameFUT3
    Gene ID2525
    Gene Symbol and SynonymsCD174,FT3B,FucT-III,FUT3,LE,Les
    Uniprot AccessionP21217
    Uniprot Entry NameFUT3_HUMAN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target, Immuno-oncology Target
    DiseaseN/A
    Gene EnsemblENSG00000171124
    Target ClassificationCheckpoint-Immuno Oncology

    The target: FUT3, gene name: FUT3, also named as CD174, FT3B, FucT-III, LE, Les. The Lewis histo-blood group system comprises a set of fucosylated glycosphingolipids that are synthesized by exocrine epithelial cells and circulate in body fluids. The glycosphingolipids function in embryogenesis, tissue differentiation, tumor metastasis, inflammation, and bacterial adhesion. They are secondarily absorbed to red blood cells giving rise to their Lewis phenotype. This gene is a member of the fucosyltransferase family, which catalyzes the addition of fucose to precursor polysaccharides in the last step of Lewis antigen biosynthesis. It encodes an enzyme with alpha(1,3)-fucosyltransferase and alpha(1,4)-fucosyltransferase activities. Mutations in this gene are responsible for the majority of Lewis antigen-negative phenotypes. Differences in the expression of this gene are associated with host susceptibility to viral infection. [provided by RefSeq, Aug 2020].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.